Clinical Trial Update: Vitamin C in Atrial Fibrillation Ablation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigated vitamin C in patients undergoing atrial fibrillation ablation; results completed and posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Atrial Fibrillation Ablation | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16